HLA-C and neoplasm: These data showed that 60 mutations producing short peptides with high binding affinity to MHC (H-2 Kb allele, median binding affinity percentile rank across all MHC binding affinity prediction algorithms <  = 2%) were predicted, and considered as potential tumor neoantigen mutations.